Navigation Links
OncoSec Medical Announces $7.2 Million Public Offering
Date:12/13/2012

SEC's website at www.sec.gov or by request at Dawson James Securities, Inc. by e-mailing placements@djsiny.com.

This announcement is neither an offer to sell nor a solicitation of an offer to buy any of OncoSec's common stock or warrants. No offer, solicitation or sale will be made in any jurisdiction in which such offer, solicitation or sale is unlawful.

About OncoSec Medical Inc.

OncoSec Medical Inc. is a biopharmaceutical company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers. ImmunoPulse and NeoPulse therapies address an unmet medical need and represent a potential solution, for less invasive and less expensive therapies that are able to minimize detrimental effects resulting from currently available cancer treatments such as surgery, systemic chemotherapy or immunotherapy and other treatment alternatives.  OncoSec Medical's core technology is based upon its proprietary use of an electroporation platform to dramatically enhance the delivery and uptake of a locally delivered DNA-based immunocytokine (ImmunoPulse) or chemotherapeutic agent (NeoPulse). Treatment of various solid cancers using these powerful and targeted anti-cancer agents has demonstrated selective destruction of cancerous cells while sparing healthy normal tissues during early and late stage clinical trials. OncoSec's clinical programs include three Phase II clinical trials for ImmunoPulse targeting lethal skin cancers. More information is available at http://www.oncosec.com/.

This press release contains forward looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered such "forward looking statements." Forward looking statements are based on management's cu
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. OncoSec Medical Issues Letter to Shareholders
3. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
4. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
5. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
6. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
7. OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
8. OncoSec Granted New Patent from China
9. OncoSec to Present at Upcoming Healthcare and Investor Conferences
10. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
11. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Pharmavite LLC announced that Timothy "Tim" Toll ... immediately. Toll recently served as Pharmavite,s executive vice president ... private label and sales administration in the ... Toll will expand his responsibilities to include international sales, ... appointment to chief customer officer is part of a ...
(Date:7/23/2014)... July 23, 2014  RT Oncology Services Corporation today ... join its board of directors. Mr. Mundie is currently ... he works on strategic projects within the company and ... chief research and strategy officer. ... RainTree, said, "Craig is a visionary technology executive. His ...
(Date:7/23/2014)... -- Top Staten Island Pediatrician Dr. Michael ... which discusses tips for parents about pool safety for children. ... According to US News article, "Drowning is the ... aged 1 to 4, and can occur in as little ... the article says that watching a child in the water ...
Breaking Medicine Technology:Craig Mundie Joins RainTree Oncology Board of Directors 2Craig Mundie Joins RainTree Oncology Board of Directors 3Premier Staten Island Pediatrician Dr. Michael Gabriel Comments On Article Discussing Pool Safety Tips for Parents 2
... 21 /PRNewswire/ Terumo Heart, Inc. today,announced the discharge of ... Assist System (LVAS). The patient was,discharged home on August ... after receiving the device., The patient is a ... heart failure for nearly 20 years. He is the ...
... have a study,that is falling behind with recruitment? Have ... media but still have not seen the,desired results? Perhaps ... to help,your sites navigate the world of media placements ... Argonauta Assist(TM) service," says Ms. Ann Kottcamp,President of Argonauta ...
Cached Medicine Technology:Discharge of First U.S. DuraHeart(TM) Patient 2Argonauta Assist(TM)ance: Argonauta Communications Strives to Enhance Site-Based Recruitment Efforts 2
(Date:7/24/2014)... 24, 2014 A new report ... 80 percent of doctors in the U.S. have upgraded to ... , Doctors appear to be embracing more digital options. Online ... linking them to past patient histories, the latest published studies, ... , A report from the Robert Wood Johnson Foundation ...
(Date:7/24/2014)... The Arm Lift, also known as brachioplasty, ... skin from the upper arms to create a more toned, ... arm can become lax and may begin to sag, resulting ... the appearance of sagging upper arms, and seek treatment to ... is now offering brachioplasty to tighten and improve the ...
(Date:7/24/2014)... The Republic of Tea, leading purveyor of premium teas, ... to celebrate “The Hundred-Foot Journey,” a new major motion picture ... hundred-foot journey begins in the moment when you bravely drop ... that is far out of your comfort zone. It is ... changes the course of your life for the better. ...
(Date:7/24/2014)... San Jose, California (PRWEB) July 24, 2014 ... market for sugar alcohols, commonly known as food polyols, ... confectionery sectors. Rising incidence of obesity, growing ... rapidly aging population vulnerable to diabetes are some of ... market. With growing number of scientific studies validating the ...
(Date:7/24/2014)... 24, 2014 Freeslate, Inc ... solutions for biopharmaceutical development, today announced its feature ... Formulations” by Jim Kling. Topics of this ... formulations and how automation can help address many ... formulations have been a growing focus of pharmaceutical ...
Breaking Medicine News(10 mins):Health News:Doctors Embracing Changing Technologies, And Technology Brings Options to Treatment 2Health News:Doctors Embracing Changing Technologies, And Technology Brings Options to Treatment 3Health News:How to Get Toned Arms With Arm Lift Procedure 2Health News:How to Get Toned Arms With Arm Lift Procedure 3Health News:The Republic of Tea Unveils New Tea Inspired by “The Hundred-Foot Journey” 2Health News:The Republic of Tea Unveils New Tea Inspired by “The Hundred-Foot Journey” 3Health News:Rising Incidence of Diabetes and Obesity Drives the Global Sugar Alcohols Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of Diabetes and Obesity Drives the Global Sugar Alcohols Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Freeslate Featured in BioProcess International Article Discussing Challenges and Solutions to Highly Concentrated Protein Formulations 2Health News:Freeslate Featured in BioProcess International Article Discussing Challenges and Solutions to Highly Concentrated Protein Formulations 3
... immediately spot the victims of a bite from the Brazilian ... and an increase in blood pressure, they also sport an ... quest for more Viagras. Scientists say they have figured out ... boost. , “The erection is a side effect ...
... the cancer cells ensure that new blood vessels feed it ... that this can be blocked by a drug commonly used ... Research at Johns Hopkins have discovered that in mice itraconazole ... "We were surprised, to say the least, that itraconazole popped ...
... millions of hours of work productivity this spring//. ,A ... including sneezing, watery eyes and runny and itchy noses, found ... peak hay fever season. ,While missing an hour ... to 50 million Americans suffer from at least some symptoms ...
... can result in serious injury and affect people of all ... yet receives little// , if any, instruction on ladder use ... the May issue of the American Journal of Preventive Medicine ... (CIRP) at Columbus Children’s Hospital, more than 2.1 million individuals ...
... survey reveals that more than one in three HIV positive gay ... in the journal Sexually// Transmitted Infections . Yet, that’s ... that they do the same. ,The findings based on ... London, Manchester, and Brighton between 2003 and 2004, involved information on ...
... dietary changes could be helpful to improve sexual dysfunction ... dysfunction (FSD) includes a variety of disorders that are ... problems with orgasm or pain during sexual activity. ... most loving relationships. It is also an extremely complex ...
Cached Medicine News:Health News:Brazil Spider Offers Hope for Those Suffering from Erectile Dysfunction 2Health News:Hay Fever Can Send Work Productivity Down the Drain 2Health News:Hay Fever Can Send Work Productivity Down the Drain 3Health News:Ladder-related Injuries on the Rise in U.S 2Health News:Condom Promotion-Crucial To HIV/AIDS Prevention 2Health News:Condom Promotion-Crucial To HIV/AIDS Prevention 3Health News:Simple Changes in Diet Could Improve Sex Life of Women 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: